Core Viewpoint - Visionary Holdings Inc. has entered into a strategic investment agreement for a US$20 million anti-aging project in Qingdao, China, aimed at establishing a research center and health management chain [1][2]. Investment Agreement Details - The agreement involves the establishment of a project company to operate the collaboration, focusing on cell therapy and biologics [2]. - The investment will be made in two phases, with the first phase comprising three milestone-based payments: 30% upon project company establishment, 40% after research center renovation, and 30% after the first flagship center opens [3]. - A second-phase investment of US$10 million is planned, contingent on the project's development progress [3]. Support Measures - The agreement includes various support measures such as local resource coordination, preferential office and R&D space, talent housing support, and assistance with business registration and approvals [4]. - There is also a plan for a Sino-U.S. international life sciences incubator to attract participants in the industry [4]. Valuation and Ownership Framework - The project's pre-investment valuation will reference the value of the Company's intellectual property and cash capital, with equity interest percentages to be finalized after due diligence [5]. - The project company will operate under exclusive technology authorization, with designated management and technical personnel [6]. Operational Goals - The project aims to achieve profitability for the first anti-aging center within one year of investment completion and to secure a leading market position within two years [6]. - The CEO of Visionary emphasized the structured framework of the agreement, including funding, milestones, and regional support [6].

Core Insights - The 8th Hainan International Health Industry Expo focuses on "Exploring New Paths for Health and Longevity, Promoting High-Quality Industry Development" [1] - Experts and industry representatives gathered to discuss ecological practices, cutting-edge technology, and industry collaboration to enhance the quality of life and longevity [1] Group 1: Key Presentations - Li Dongke, Chairman of Renshang Jiyie Group, presented on "Forest Therapy: Realizing Longevity Value," discussing the concept of "forest hospitals" and its implementation in Wuzhishan, showcasing an innovative model for converting ecological resources into health value [1] - Zhang Wang, Head of Huawei Terminal BG Hainan Business Department, demonstrated Huawei's capabilities in proactive health management through the "Huawei Qingtian" technology, providing a new, practical approach to health management [1] - Liu Zhenyu, a fourth-generation inheritor of traditional Chinese medicine, shared insights on health and longevity practices, offering modern individuals applicable health lifestyle methods [1] Group 2: Strategic Collaborations - Renshang Jiyie Group signed a cooperation agreement with Hainan Boao Super Hospital to establish the "Hainan Longevity Medical Demonstration Base" [2] - Renshang Jiyie Group also reached a deep cooperation agreement with the China Immunity Anti-Aging and Microecology Research Institute to jointly develop the Wuzhishan base project, injecting new momentum into the integration of anti-aging industry and modern medicine [2]